Jonathan Katchmore

Jonathan Katchmore is an accomplished professional with extensive experience in the pharmaceutical and diagnostics industries. Most recently, Jonathan served as the Associate Vice President of Commercial Diagnostic Strategy at Eli Lilly and Company and as Precision Medicine Director for Lilly Oncology from September 2020 to March 2023. Prior to this role, Jonathan held positions at Loxo Oncology, Inc., where responsibilities included Precision Medicine Director and Director of Diagnostic Account Strategy, from May 2018 to September 2020. From July 2012 to May 2018, Jonathan was the Mid-Atlantic Regional Sales Director at Foundation Medicine, a company focused on enhancing cancer care through genomic profiling. Jonathan's career also includes experience with Myriad Genetics as an Oncology Product Specialist and positions at sanofi-aventis. Jonathan earned a Bachelor of Science in Operations & Information Management from the University of Scranton.